Skip to content

Bio-Rad Laboratories, Inc.

BIO BIO-B

CIK 0000012208

← back to feed
Revenue (TTM)
$2.48B
+0.7% YoY Q1 Mar 2026
Net Income (TTM)
−$487.2M
+206.2% YoY Q1 Mar 2026
EPS Diluted (TTM)
−$18.29
+208.9% YoY Q1 Mar 2026
Gross Margin
52.5%
Q1 Mar 2026
Operating Margin
8.1%
Q1 Mar 2026
Net Margin
-19.6%
Q1 Mar 2026
Free Cash Flow (TTM)
$265.59M
Q1 Mar 2026
Cash
$507.2M
Q1 Mar 2026
Total Debt
$803.1M
Q1 Mar 2026
Shares Outstanding
27.67M sh
Q1 Mar 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings